SCHEMBL10275534

SCHEMBL10275534

Cc1nn2c(=O)c3ccc(-c4ccc(N)cc4)cc3[nH]c2c1-c1ccc(F)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 4/20 0.40
HAVCR2 Q8TDQ0 1/20 0.37
FEN1 P39748 2/20 0.36
PGR P06401 1/20 0.35
NR3C2 P08235 1/20 0.35
ARF6 P62330 2/20 0.35
KIT P10721 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
THRB P10828 1/20 0.34
HPGD P15428 1/20 0.34
CYP3A4 P08684 1/20 0.34
DHODH Q02127 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
PTGES O14684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275519 0.89 ARF6 (0.39) TNKS2FEN1PGRNR3C2ARF6
SCHEMBL10275272 0.89 MEN1 (0.43) TNKS2MEN1KMT2AALDH1A1HPGD
SCHEMBL10275539 0.88 FLT3 (0.39) TNKS2ARF6KMT2A
SCHEMBL10276103 0.83 PGR (0.37) PGRNR3C2ARF6KITMEN1
SCHEMBL10275647 0.82 ADORA2B (0.38) TNKS2PGRNR3C2MEN1KMT2A
SCHEMBL10313546 0.81 ARF6 (0.41) TNKS2FEN1PGRNR3C2ARF6
SCHEMBL10275495 0.80 TNKS2 (0.36) TNKS2HAVCR2FEN1KITCYP3A4
SCHEMBL10276014 0.80 PGR (0.38) PGRNR3C2ARF6KITMEN1
SCHEMBL10275685 0.80 DHODH (0.39) PGRNR3C2ARF6KITMEN1
SCHEMBL10313549 0.77 MAPT (0.45) MEN1KMT2AALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 TNKS2 2499/4885HAVCR2 790/4885FEN1 1832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.